◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

ENZON PHARMACEUTICALS, INC.

CIK: 727510 SIC: 2836
-
Revenue
$-3.41M
Net Income
-
Gross Margin
-
Op. Margin
$-4.92M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 43 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue - - - - - $26.00K $26.00K - - - - - $26.00K -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $1.47M $1.30M $1.53M $1.00M $325.00K $351.00K $351.00K $326.00K $216.00K $225.00K $318.00K $285.00K $237.00K $221.00K
+ Operating Income $-1.47M $-1.30M $-1.53M $-1.00M $-325.00K $-351.00K $-325.00K $-326.00K $-216.00K $-225.00K $-318.00K $-285.00K $-211.00K $-221.00K
Operating Margin % nan% nan% nan% nan% nan% -1350.0% -1250.0% nan% nan% nan% nan% nan% -811.5% nan%
Income Before Tax $-1.04M $-808.00K $-1.03M $-505.00K $221.00K $303.00K $280.00K $321.00K $423.00K $397.00K $235.00K $162.00K $135.00K $-13.00K
Income Tax Expense $26.00K $16.00K $-42.00K $19.00K $293.00K $49.00K $4.00K $1.00K $-249.00K $76.00K $52.00K $-35.00K $-198.00K $2.00K
+ Net Income $-1.07M $-824.00K $-990.00K $-524.00K $-72.00K $254.00K $276.00K $320.00K $672.00K $321.00K $183.00K $197.00K $333.00K $-15.00K
Net Margin % nan% nan% nan% nan% nan% 976.9% 1061.5% nan% nan% nan% nan% nan% 1280.8% nan%
Basic EPS -0.02 -0.02 -0.02 -0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 -0.01
Diluted EPS -0.02 -0.02 -0.02 -0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 -0.01
Basic Shares Outstanding - 74.2M 74.2M 74.2M - 74.2M 74.2M 74.2M - 74.2M 74K 74K -74.1M 74.2M
Diluted Shares Outstanding - 74.2M 74.2M 74.2M - 74.2M 74.2M 74.2M - 74.2M 74K 74K -74.1M 74.2M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $42.57M $43.26M $44.29M $44.97M $46.86M $46.63M $46.23M $45.99M $47.01M $46.56M $46.13M $45.88M $46.98M $46.85M
Other Current Assets $239.00K $411.00K $444.00K $555.00K $293.00K $337.00K $409.00K $481.00K $331.00K $329.00K $354.00K $380.00K $405.00K $405.00K
Total Current Assets $42.81M $43.67M $44.74M $45.52M $47.15M $46.97M $46.64M $46.47M $47.34M $46.89M $46.48M $46.26M $47.39M -
Total Assets $42.81M $43.69M $44.78M $45.52M $47.17M $47.28M $46.99M $46.83M $47.70M $47.00M $46.67M $46.49M $47.59M $47.26M
Accounts Payable $331.00K $331.00K $331.00K $331.00K $331.00K $331.00K $331.00K $331.00K $331.00K $337.00K $331.00K $331.00K $331.00K $331.00K
Accrued Liabilities $400.00K $209.00K $472.00K $223.00K $72.00K $107.00K $79.00K $190.00K $108.00K $69.00K $71.00K $77.00K $93.00K $94.00K
Total Current Liabilities $731.00K $540.00K $803.00K $554.00K $1.68M $438.00K $410.00K $521.00K $1.71M $406.00K $402.00K $408.00K $1.70M $425.00K
Common Stock $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K $742.00K
Retained Earnings $-73.30M $-72.23M $-71.41M $-70.42M $-69.89M $-69.82M $-70.07M $-70.35M $-70.67M $-71.34M $-71.66M $-71.85M $-72.04M $-72.38M
Total Stockholders Equity $-2.52M $-923.00K $432.00K $1.95M $3.01M $2.76M $3.04M $3.29M $-3.50M $2.52M $2.73M $3.07M $3.41M $2.76M
Total Liabilities & Equity $42.81M $43.69M $44.78M $45.52M $47.17M $47.28M $46.99M $46.83M $47.70M $47.00M $46.67M $46.49M $47.59M $47.26M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-1.07M $-824.00K $-1.51M $-524.00K $-72.00K $254.00K $596.00K $320.00K $672.00K $701.00K $380.00K $197.00K $333.00K $-15.00K
Deferred Income Tax $26.00K $16.00K $42.00K $17.00K $289.00K $50.00K $3.00K $-1.00K $-248.00K $76.00K $51.00K $-36.00K $-202.00K -
Operating Cash Flow $-682.00K $-2.33M $-1.29M $-618.00K $226.00K $896.00K $492.00K $251.00K $455.00K $850.00K $424.00K $170.00K $130.00K $-789.00K
Dividends Paid - $1.27M $1.27M $1.27M - $1.27M $1.27M $1.27M - $1.27M $1.27M $1.27M - -
Financing Cash Flow - $-1.27M $-1.27M $-1.27M - $-1.27M $-1.27M $-1.27M - $-1.27M $-1.27M $-1.27M - -
Net Change in Cash $-682.00K $-3.60M $-2.56M $-1.89M $226.00K $-379.00K $-783.00K $-1.02M $455.00K $-425.00K $-851.00K $-1.10M $130.00K $-789.00K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $1.30M - $3.84M -
Operating Income $-1.30M - $-3.84M -
Income Before Tax $-808.00K - $-2.35M -
Income Tax Expense $16.00K - $-7.00K -
Net Income $-824.00K $276.00K $-2.34M -
Basic EPS -0.02 - -0.05 -
Diluted EPS -0.02 - -0.05 -
Basic Shares Outstanding $74.22M - $74.22M -
Diluted Shares Outstanding $74.22M - $74.22M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $43.26M $46.86M
Other Current Assets $411.00K $293.00K
Total Current Assets $43.67M $47.15M
Total Assets $43.69M $47.17M
Accounts Payable $331.00K $331.00K
Accrued Liabilities $209.00K $72.00K
Total Current Liabilities $540.00K $1.68M
Common Stock $742.00K $742.00K
Retained Earnings $-72.23M $-69.89M
Total Stockholders Equity $-923.00K $3.01M
Total Liabilities & Equity $43.69M $47.17M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-824.00K $276.00K $-2.34M -
Deferred Income Tax $16.00K - $-9.00K -
Operating Cash Flow - - $-2.33M -
Dividends Paid - - $1.27M -
Financing Cash Flow - - $-1.27M -
Net Change in Cash - - $-3.60M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...